About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | 18F-FES PET/CT's Additional Clinical Value in ER+ BC

18F-FES PET/CT's Additional Clinical Value in ER+ BC

NCT04006626·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Fudan University

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients with newly diagnosed immunohistochemical confirmed oestrogen receptor (ER)-positive breast cancer
Patients underwent both 18F-FES PET/CT and 18F-FDG PET/CT in Fudan University Shanghai Cancer Center within 1 week after diagnosis
Patients with available medical history

You may not be if

Patients with incomplete medical history

The record

StatusCompleted

PhaseNo phase

Taking part19

StartedFeb 2019

UpdatedJul 5, 2019

Conditions

Where1

Biyun Wang, MD
Shanghai, Shanghai Municipality, China